LIFEVANTAGE CORP Adjustments to Additional Paid in Capital, Warrant Issued
LIFEVANTAGE CORP (LFVN) reported Adjustments to Additional Paid in Capital, Warrant Issued of $0 for the 12-month period ending 2013-06-30, per its 10-K filed 2015-09-01.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2015-09-01
- LIFEVANTAGE CORP adjustments to additional paid in capital, warrant issued for the quarter ending 2012-06-30 was -$71.00.
- LIFEVANTAGE CORP adjustments to additional paid in capital, warrant issued for the quarter ending 2012-03-31 was $0.00.
- LIFEVANTAGE CORP adjustments to additional paid in capital, warrant issued for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- LIFEVANTAGE CORP adjustments to additional paid in capital, warrant issued for fiscal 2012 was $16.48M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month as first filed |
|---|---|---|---|---|---|
| 2013-06-30 | $0.00 10-K · filed 2015-09-01 | ||||
| 2012-06-30 | -$71.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-10 | -$71.00 derived: sum of 2 quarters · filed 2014-09-10 | $16.48M 10-K · filed 2014-09-10 | $16.48M 10-K · filed 2012-09-10 | |
| 2012-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-15 | $16.48M 10-Q · filed 2012-05-15 | |||
| 2011-12-31 | $16.48M 10-Q · filed 2012-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |